Endometrial Cancer 2019 Global Market Key Players – Pfizer Inc., General Electri

Endometrial Cancer Market - Overview

The abnormal growth of endometrium cells in the uterus is termed as endometrial cancer which is also known as uterine cancer. Endometrial cancer is diagnosed at an early stage as women experience abnormal vaginal bleeding.

It is reported that endometrial cancer is the sixth most common cancer in women all over the world. The endometrial cancer market is expected to witness a tremendous growth owing to the rising prevalence of endometrial cancer.

GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6226

Other key factors such as the growing obesity among women, increase in menopausal hormone therapy, change in sedentary lifestyle, socioeconomic factors, growing consumption of unhealthy diet, increasing occurrence of Polycystic Ovarian Syndrome (PCOS), and increasing prevalence of breast or ovarian tumor are contributing towards the growth of the market. 

Diabetes is another risk factor that leads to the development of endometrial cancer. According to the American Cancer Society, endometrial cancer is four times common in diabetic women than in normal women. Such factors contribute to endometrial cancer among women.

The prominent players involved in the market are

•          Pfizer Inc.
•          General Electric Company
•          Koninklijke Philips N.V.
•          LUPIN
•          PHYTON
•          Bayer AG
•          Celgene Corporation
•          Johnson & Johnson
•          CooperSurgical Inc.
•          LiNA Medical USA
•          Conceptus Inc.

And More

Endometrial Cancer Market -Industry Trends

According to the Journal of Clinical Oncology, researchers of John Hopkins Medicine have found a new way to treat uterine cancer by adding the drug trastuzumab to the chemotherapy regimen of the uterine cancer patients.

PapSEEK is a type of liquid biopsy which is now enabling researchers to identify endometrial cancer at a very early stage. The screening procedure is still in its early stage, but it can surely benefit the doctors in diagnosing and treating their patients.

OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226

Endometrial Cancer Market -Segmentation

The global endometrial cancer market is segmented on the basis of diagnosis, treatment, and end-user. The endometrial cancer market, by diagnosis, is categorized into pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy.

On the basis of treatment, the market is segmented into hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. The hysterectomy techniques category includes open abdominal hysterectomy, total vaginal hysterectomy, total laparoscopic hysterectomy, and robotic hysterectomy.

The radiation category includes external radiation and internal radiation (brachytherapy). The hormonal therapy includes progestins, tamoxifen, luteinizing hormone-releasing hormone agonists, and aromatase inhibitors.

The chemotherapy segment is categorized into paclitaxel, carboplatin, doxorubicin, and cisplatin. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.    

Endometrial Cancer Market - Regional Analysis

On the basis of region, the global endometrial cancer market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America.

The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe.

The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

GET MORE INFORMATION:

https://www.medgadget.com/2018/11/2018-2023-global-endometrial-cancer-market-to-perceive-substantial-growth-industry-structure-segmentation-assessment-competitive-landscape-penetration.html

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

About This Author

Karishma Shikalgar Joined: January 28th, 2019